Wonbiogen Co Ltd
KOSDAQ:307280
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Wonbiogen Co Ltd
Selling, General & Administrative
Wonbiogen Co Ltd
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
W
|
Wonbiogen Co Ltd
KOSDAQ:307280
|
Selling, General & Administrative
-₩8.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-139%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Selling, General & Administrative
-₩79.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-18%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Selling, General & Administrative
-₩62.2B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-106%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Selling, General & Administrative
-₩35.7B
|
CAGR 3-Years
-634%
|
CAGR 5-Years
-320%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Selling, General & Administrative
-₩8.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-228%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Selling, General & Administrative
-₩7.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Wonbiogen Co Ltd
Glance View
Wonbiogen Co., Ltd. engages in the research and development of biocompatible medical materials. The company is headquartered in Gumi, Gyeongsangbuk-Do. The company went IPO on 2018-12-05. The firm provides medical products including dressing material used for lower leg ulcers, pressure ulcers and surgical wounds; dressing material for secretions absorption and wound area protection; fixing band for bandages, gauze, catheters, along with others.
See Also
What is Wonbiogen Co Ltd's Selling, General & Administrative?
Selling, General & Administrative
-8.2B
KRW
Based on the financial report for Sep 30, 2025, Wonbiogen Co Ltd's Selling, General & Administrative amounts to -8.2B KRW.
What is Wonbiogen Co Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-139%
Over the last year, the Selling, General & Administrative growth was -6%. The average annual Selling, General & Administrative growth rates for Wonbiogen Co Ltd have been 1% over the past three years , -139% over the past five years .
